NASDAQ:RNXT • US75989R1077
Taking everything into account, RNXT scores 3 out of 10 in our fundamental rating. RNXT was compared to 521 industry peers in the Biotechnology industry. RNXT has a great financial health rating, but its profitability evaluates not so good. RNXT has a expensive valuation and it also scores bad on growth.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -99.1% | ||
| ROE | -137.47% | ||
| ROIC | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 67.78% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -3.11 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.83 | ||
| Quick Ratio | 5.68 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:RNXT (2/17/2026, 8:00:02 PM)
0.98
+0.05 (+5%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 38.7 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 4.45 | ||
| P/tB | 4.45 | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -99.1% | ||
| ROE | -137.47% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 67.78% | ||
| FCFM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.83 | ||
| Quick Ratio | 5.68 | ||
| Altman-Z | -3.11 |
ChartMill assigns a fundamental rating of 3 / 10 to RNXT.
ChartMill assigns a valuation rating of 1 / 10 to RENOVORX INC (RNXT). This can be considered as Overvalued.
RENOVORX INC (RNXT) has a profitability rating of 1 / 10.
The Earnings per Share (EPS) of RENOVORX INC (RNXT) is expected to grow by 18.4% in the next year.